• Chief Healthcare ExecutiveChief Healthcare Executive
  • Formulary WatchFormulary Watch
  • Managed Healthcare Executive
  • Medical EconomicsMedical Economics
Managed Healthcare Executive
Managed Healthcare Executive
Resource Centers
View MoreHIVLiver DiseaseSleep DisordersBiosimilarsCovid-19AsthmaMultiple SclerosisPost-Acute CarePrescription Digital TherapeuticsRespiratory ConditionsType II Inflammation
Spotlight
Asembia’s 2022 Specialty Pharmacy SummitAMCP AnnualThe Improving Patient Access PodcastWet Age-Related Macular Degeneration: Understanding Disease Impact and Refining Treatment ApproachesAMCP NexusParadigms in Insulin Use for Type 2 DiabetesPBMI National ConferenceRespiratory ConditionsShort on staff? Efficiency—not hiring—may be the best answerSupporting Better Cancer Care Through Comprehensive Genomic Profiling (CGP)
Business
View MoreBusiness StrategyChronic DiseaseConsumersDrug CostsDrug PipelineFormularyHealth ManagementHealth/Disease StrategyHospitals & ProvidersIndustry AnalysisPharmacyPolitics and PolicyPractice ManagementReimbursementTechnology
News
Media
Expert Interviews
K-Cast
Medical World News
Podcasts
Population Health Perspectives
Conferences
Publications
MHE Publication
Supplements And Featured Publications
Events
Virtual Events
CME/CE
Resources
PBM Leaders
Sponsored
Sponsored Content
Surveys
Subscribe
eNewsletter
Print Subscription
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Informations

© 2022 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.

Resource CentersSee All >
  • HIV
  • Liver Disease
  • Sleep Disorders
  • Biosimilars
  • Covid-19
  • Asthma
  • Multiple Sclerosis
  • Post-Acute Care
  • Prescription Digital Therapeutics
  • Respiratory Conditions
  • Type II Inflammation
Spotlight
  • Asembia’s 2022 Specialty Pharmacy Summit
  • AMCP Annual
  • The Improving Patient Access Podcast
  • Wet Age-Related Macular Degeneration: Understanding Disease Impact and Refining Treatment Approaches
  • AMCP Nexus
  • Paradigms in Insulin Use for Type 2 Diabetes
  • PBMI National Conference
  • Respiratory Conditions
  • Short on staff? Efficiency—not hiring—may be the best answer
  • Supporting Better Cancer Care Through Comprehensive Genomic Profiling (CGP)
BusinessSee All >
  • Business Strategy
  • Chronic Disease
  • Consumers
  • Drug Costs
  • Drug Pipeline
  • Formulary
  • Health Management
  • Health/Disease Strategy
  • Hospitals & Providers
  • Industry Analysis
  • Pharmacy
  • Politics and Policy
  • Practice Management
  • Reimbursement
  • Technology
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Informations
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.

Chronic Disease

  1. home
  2. business
  3. chronic-disease

Dupixent Safe, Effective Up to Four Years in Adults With Moderate-to-Severe Atopic Dermatitis

May 09, 2022

Safe and effective long-term treatment is important for stable disease control in atopic dermatitis.

There Remains an Unmet Need for EoE Treatments That Provide Effective, Long-term Disease Control

May 05, 2022

Patients with eosinophilic esophagitis (EoE) are faced with delayed diagnosis, burdens related to symptoms, quality of life and cost, but lack targeted systemic therapies to improve long-term disease control.

A Dangerous Pairing: COVID-19 & Obesity - Heightened Risk for COVID-19 Severity

March 15, 2022

Seeing LDL Cholesterol in a New Light

November 11, 2021

Treating high levels of low-density lipoprotein cholesterol in young people may reduce lifetime exposure and lead to fewer cases of coronary heart disease.

Stemming the Rising Tide of Insulin Prices

September 16, 2021

States are putting caps on prices, and Semglee, the first interchangeable biosimilar in the United States, may exert some downward pressure.

Listen to Your Body and Heart. Avoiding Doctor Visits Won't Stop Potential Disease.

August 17, 2021

Many people ignored heart disease signs and symptoms during the COVID-19 pandemic — sometimes with grave consequences.

Specialists are Testing the Value-based Care Waters

July 21, 2021

After having thrived in a fee-for-service healthcare system, can chronic disease specialists be enticed to switch?

Psychedelics Take a Long, Strange Trip to Respectability

June 09, 2021

Research and investment are increasing into psilocybin and MDMA as treatments for several mental health disorders.

3 Takeaways About Managing the Cost of MS

May 21, 2021

Multiple sclerosis is dependably among the most expensive chronic diseases to treat, but there are ways to reduce the size of the bill.

Knowing SDOH is Good Medicine

April 26, 2021

Paying attention to the social determinants of health may be a powerful way of improving cardiovascular outcomes.